321 related articles for article (PubMed ID: 33408525)
21. Premature aging/senescence in cancer cells facing therapy: good or bad?
Gonzalez LC; Ghadaouia S; Martinez A; Rodier F
Biogerontology; 2016 Feb; 17(1):71-87. PubMed ID: 26330289
[TBL] [Abstract][Full Text] [Related]
22. Targeting senescence as an anticancer therapy.
Bousset L; Gil J
Mol Oncol; 2022 Nov; 16(21):3855-3880. PubMed ID: 36065138
[TBL] [Abstract][Full Text] [Related]
23. The senescence-associated secretory phenotype in ovarian cancer dissemination.
Veenstra JP; Bittencourt LFF; Aird KM
Am J Physiol Cell Physiol; 2022 Jul; 323(1):C125-C132. PubMed ID: 35584328
[TBL] [Abstract][Full Text] [Related]
24. Tumor microenvironment and cellular senescence: Understanding therapeutic resistance and harnessing strategies.
Liu H; Zhao H; Sun Y
Semin Cancer Biol; 2022 Nov; 86(Pt 3):769-781. PubMed ID: 34799201
[TBL] [Abstract][Full Text] [Related]
25. Therapy-Induced Stromal Senescence Promoting Aggressiveness of Prostate and Ovarian Cancer.
Pardella E; Pranzini E; Nesi I; Parri M; Spatafora P; Torre E; Muccilli A; Castiglione F; Fambrini M; Sorbi F; Cirri P; Caselli A; Puhr M; Klocker H; Serni S; Raugei G; Magherini F; Taddei ML
Cells; 2022 Dec; 11(24):. PubMed ID: 36552790
[TBL] [Abstract][Full Text] [Related]
26. Two-Step Senescence-Focused Cancer Therapies.
Sieben CJ; Sturmlechner I; van de Sluis B; van Deursen JM
Trends Cell Biol; 2018 Sep; 28(9):723-737. PubMed ID: 29776716
[TBL] [Abstract][Full Text] [Related]
27. Bafilomycin A1 triggers proliferative potential of senescent cancer cells in vitro and in NOD/SCID mice.
Was H; Barszcz K; Czarnecka J; Kowalczyk A; Bernas T; Uzarowska E; Koza P; Klejman A; Piwocka K; Kaminska B; Sikora E
Oncotarget; 2017 Feb; 8(6):9303-9322. PubMed ID: 28030837
[TBL] [Abstract][Full Text] [Related]
28. Targeting tumor cell senescence and polyploidy as potential therapeutic strategies.
Saleh T; Carpenter VJ; Bloukh S; Gewirtz DA
Semin Cancer Biol; 2022 Jun; 81():37-47. PubMed ID: 33358748
[TBL] [Abstract][Full Text] [Related]
29. The role of senescence in cancer development.
Mavrogonatou E; Pratsinis H; Kletsas D
Semin Cancer Biol; 2020 May; 62():182-191. PubMed ID: 31260734
[TBL] [Abstract][Full Text] [Related]
30. Targeting normal and cancer senescent cells as a strategy of senotherapy.
Sikora E; Bielak-Zmijewska A; Mosieniak G
Ageing Res Rev; 2019 Nov; 55():100941. PubMed ID: 31408714
[TBL] [Abstract][Full Text] [Related]
31. Cellular senescence in glioma.
Chojak R; Fares J; Petrosyan E; Lesniak MS
J Neurooncol; 2023 Aug; 164(1):11-29. PubMed ID: 37458855
[TBL] [Abstract][Full Text] [Related]
32. Senescence and castration resistance in prostate cancer: A review of experimental evidence and clinical implications.
Carpenter VJ; Patel BB; Autorino R; Smith SC; Gewirtz DA; Saleh T
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188424. PubMed ID: 32956765
[TBL] [Abstract][Full Text] [Related]
33. Pro- and anti-tumorigenic functions of the senescence-associated secretory phenotype.
Lau L; David G
Expert Opin Ther Targets; 2019 Dec; 23(12):1041-1051. PubMed ID: 30616404
[No Abstract] [Full Text] [Related]
34. Distinct phenotypes and 'bystander' effects of senescent tumour cells induced by docetaxel or immunomodulatory cytokines.
Sapega O; Mikyšková R; Bieblová J; Mrázková B; Hodný Z; Reiniš M
Int J Oncol; 2018 Nov; 53(5):1997-2009. PubMed ID: 30226595
[TBL] [Abstract][Full Text] [Related]
35. Unraveling Adipocytes and Cancer Links: Is There a Role for Senescence?
Wu Q; Li B; Sun S; Sun S
Front Cell Dev Biol; 2020; 8():282. PubMed ID: 32411704
[TBL] [Abstract][Full Text] [Related]
36. Metronomic topotecan impedes tumor growth of MYCN-amplified neuroblastoma cells in vitro and in vivo by therapy induced senescence.
Taschner-Mandl S; Schwarz M; Blaha J; Kauer M; Kromp F; Frank N; Rifatbegovic F; Weiss T; Ladenstein R; Hohenegger M; Ambros IM; Ambros PF
Oncotarget; 2016 Jan; 7(3):3571-86. PubMed ID: 26657295
[TBL] [Abstract][Full Text] [Related]
37. An untapped window of opportunity for glioma: targeting therapy-induced senescence prior to recurrence.
Riviere-Cazaux C; Carlstrom LP; Neth BJ; Olson IE; Rajani K; Rahman M; Ikram S; Mansour MA; Mukherjee B; Warrington AE; Short SC; von Zglinicki T; Brown DA; Burma S; Tchkonia T; Schafer MJ; Baker DJ; Kizilbash SH; Kirkland JL; Burns TC
NPJ Precis Oncol; 2023 Nov; 7(1):126. PubMed ID: 38030881
[TBL] [Abstract][Full Text] [Related]
38. The senescence journey in cancer immunoediting.
Zingoni A; Antonangeli F; Sozzani S; Santoni A; Cippitelli M; Soriani A
Mol Cancer; 2024 Apr; 23(1):68. PubMed ID: 38561826
[TBL] [Abstract][Full Text] [Related]
39. Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies.
Xu J; Zhou L; Liu Y
Front Pharmacol; 2020; 11():601325. PubMed ID: 33362554
[TBL] [Abstract][Full Text] [Related]
40. Quantifying Senescence-Associated Phenotypes in Primary Multipotent Mesenchymal Stromal Cell Cultures.
Nadeau S; Cheng A; Colmegna I; Rodier F
Methods Mol Biol; 2019; 2045():93-105. PubMed ID: 31020633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
